Global GI Endoscopy Guidewire Market - 2021-2028
|出版日期||內容資訊||英文 180 Pages
|GI內視鏡用導管導引線的全球市場(2021年∼2028年) Global GI Endoscopy Guidewire Market - 2021-2028|
|出版日期: 2021年06月14日||內容資訊: 英文 180 Pages||
The global GI endoscopy guidewire market size was valued US$ XX billion in 2019 and is estimated to reach US$ XX billion by 2028, growing at a CAGR of XX % during the forecast period (2021-2028).
Endoscopy is a non-surgical procedure that is used to examine a person's digestive tract. Guidewires have become indispensable tools in diagnostic and therapeutic endoscopy to maintain access to a lumen or cavity and facilitate the advancement of several devices. These are usually used to advance rigid and balloon dilators, feeding tubes, manometry catheters, stents, and during transmucosal pseudocyst drainage in the upper GI endoscopy.
The GI endoscopy guidewire market growth is driven by the increasing geriatric population globally, rising adoption of minimally invasive therapies and presence of favorable medical reimbursement policies, growing research and development activities.
Rising adoption of minimally invasive therapies, is expected to drive the global GI endoscopy guidewire market growth
The endoscopic surgeries are witnessing strong gains as endoscopic imaging has become the primary technique for detecting and treating chronic and acute diseases due to its unique capability of targeting hard-to-reach areas. Minimally invasive procedures have evolved into highly accurate, sensitive, and less invasive surgical procedures and also owing to benefits like lesser hospital stays, reduction in cost, better patient experience, faster recovery is attributed to the growth of the market. This, combined with advantages offered by advanced guidewire features such as improved vision, superior lesion access, and low procedural cost, is projected to drive the growth of the market.
Attractive medical reimbursement policies to increase the adoption of guidewires, is expected to drive the global GI endoscopy guidewire market growth
Favorable medical reimbursement policies initiated by government authorities are expected to drive the growth of the market. For instance, according to the 2019 GI Endoscopy Guide Medicare Reimbursement Guide published by Cook Medical, the government provides reimbursement of an estimated USD 1245.4 for Endoscopic retrograde cholangiopancreatography with guidewires procedure at ambulatory surgery centers. Therefore, strict implementation of such reimbursement policies is likely to encourage guidewires in surgical procedures, which will eventually drive the guidewire's market.
Lack of trained professionals is likely to hinder the market growth
The providers of GI endoscopy should be trained specifically to provide procedural sedation across the sedation continuum, from minimal through moderate sedation. In addition, this training should include skills in recognizing when the level of sedation is deeper than planned and the ability to rescue patients when this occurs. This lack of trained professionals may restrict the market growth.
COVID-19 Impact Analysis
COVID-19 is caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), this outbreak led to a worldwide pandemic that started in early 2020. As a result, Healthcare systems worldwide encountered a rise of COVID-19 patients resulting in more than half a million deaths globally. COVID-19 has affected multiple sub-specialties and procedure-related fields, including gastroenterology. Gastrointestinal (GI) endoscopy centers are specialized units where thousands of endoscopies are performed annually. A major proportion of these procedures are affected due to the national and regional lockdowns across the globe. To adapt to this rapidly evolving situation, endoscopy centers have undergone significant changes and have taken unprecedented precautions to avoid the transmission of the virus. However, endoscopy centers are going through financial strain due to a reduction in the number of procedures from lockdowns and fear of virus transmission.
The nitinol segment is expected to hold largest share in this market segment
The nitinol segment served the largest share of the market. Nitinol is also known as nickel-titanium alloy, contains nearly an equal amount of nickel and titanium. Therefore, it has significant applications in medical devices where its unique properties allow minimally invasive surgery and implants to improve the quality of life for people. Moreover, its significant properties, such as nonmagnetic, corrosion resistance, biocompatible, and heat resistance, better flexibility have further boosted the market growth.
The Coated guidewire segment is expected to hold largest share in this market segment
Coated endoscopy guidewire accounted for the majority of the market share owing to high demand. These products reduce friction, preserve tactile feel, and allow easy access. As a result, hydrophilic coated guidewires are highly used. This is owing to a high preference for hydrophilic coated guidewires in the ERCP procedures. This hydrophilic nature of the guidewires results in the chemical interaction with water to form a hydrogel material that exhibits low friction coefficients.
For instance, Key Surgical, a Hydrophilic guidewire, provides soft, kink-resistant coated shaft atraumatic delivery through the GI tract/orifices. In addition, Zebra-coating provides a clear vision for wire positioning and movement.
The upper GI endoscopy segment is expected to hold largest share in this market segment
The Upper GI endoscopy segment accounts significant share of the market. To maintain access to a lumen or cavity and facilitate the advancement of several devices, guidewires have become indispensable tools in diagnostic and therapeutic endoscopy. They are used to advance rigid and balloon dilators, stents, feeding tubes, manometry catheters, and during transmucosal pseudocyst drainage in the upper GI endoscopy.
The hospitals segment is expected to hold largest share in this market segment
A rise in the demand for medical devices from hospitals is likely to drive the demand for guidewires in a hospital setting-increasing gastrointestinal surgeries in hospitals. For instance, according to Becker's review of GI and Endoscopy in ASCs, in the U.S., around 25% of all cases in ASCs involve GI/endoscopic procedures. Also, more than 27% of all single-specialty surgery centers are driven due to gastroenterology procedures.
North America region holds the largest market share of global GI endoscopy guidewire market
North America held the global market share due to technological innovations that have led to product enhancements such as tip design, retention, and flexibility, resulting in the constant development of technically advanced products. Moreover, the presence of a well-defined regulatory framework, better healthcare infrastructure, and experienced healthcare professionals to perform the procedures are some of the key factors leading to the market's growth. Additionally, key players such as Terumo Medical Corporation, Boston Scientific Corporation, Abbott, Cardinal Health, AngioDynamics, and B. Braun Melsungen AG are also indicators that depict its current huge market potential. For instance, For instance, in May 2015, Terumo Medical Corporation collaborated with Olympus Corporation for the exclusive distributorship of Glidewire and urologic hydrophilic-coated guidewire.
The global GI endoscopy guidewire market is highly competitive with presence of global companies. Some of the key players which are contributing to the growth of the market include CONMED Corporation, COOK MEDICAL Inc, HOBBS MEDICAL INC, Boston Scientific Corporation, Olympus Corporation, Medico's-Hirata Inc, Sumitomo Bakelite Co., Ltd., Diagmed Healthcare, Omnimed Ltd, Merit medical systems, Inc, Hunan Reborn Medical Science Technology Development Co., Ltd, PLS Minimally Invasive Interventional Medical Co., LTD, Zhejiang Chuangxiang Medical Technology Co., Ltd. The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of the market globally. For instance, Cook Medical announced the launch of two in one guidewire, Motion Hybrid Wire Guide, with combined features of Teflon fixed core wire and nitinol access wire in January 2017.
GI Endoscopy Guidewire Market Key Companies to Watch
Boston Scientific Corporation
Overview: The company was founded in 1979. it has headquarters in United States. It develops, manufactures, and markets minimally invasive medical devices. The Company's products are used in interventional cardiology, cardiac rhythm management, peripheral interventions, electrophysiology, neurovascular intervention, endoscopy, urology, gynecology, and neuromodulation. Globally the company has business in US, EMEA, Asia-Pacific, Latin America and Canada.
Product Portfolio: The company works through the segments MedSurg which includes Endoscopy, Urology and Pelvic health, Rhythm and Neuro, Cardiovascular, Specialty pharmaceuticals.
Product: The Dreamwire High Performance Guidewire has a 10cm hydrophilic Dream Tip™ End, designed for soft, smooth access. Its Endo-Glide™ Coating promotes smooth tracking and enhances tactile sensation.
The global GI endoscopy guidewire market report would provide an access to an approx. 61 market data table, 54 figures and 200 pages.
Global GI Endoscopy Guidewire Market - By Material
Global GI Endoscopy Guidewire Market - By Indication
Global GI Endoscopy Guidewire Market - By End-User
Global GI Endoscopy Guidewire Market - By Design
Global GI Endoscopy Guide Market - By Region